• 5610 Citations
  • 31 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

  • 5610 Citations
  • 31 h-Index
  • 128 Article
  • 2 Review article
2015
14 Citations (Scopus)

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors

Khoury, H. J., Cortes, J., Baccarani, M., Wetzler, M., Masszi, T., Digumarti, R., Craig, A., Benichou, A. C. & Akard, L., Jan 1 2015, In : Leukemia and Lymphoma. 56, 1, p. 120-127 8 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Cytogenetics
Leukemia, Myeloid, Accelerated Phase
Blast Crisis
33 Citations (Scopus)

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

Stone, R. M., Mazzola, E., Neuberg, D., Allen, S. L., Pigneux, A., Stuart, R. K., Wetzler, M., Rizzieri, D., Erba, H. P., Damon, L., Jang, J. H., Tallman, M. S., Warzocha, K., Masszi, T., Sekeres, M. A., Egyed, M., Horst, H. A., Selleslag, D., Solomon, S. R., Venugopal, P. & 2 others, Lundberg, A. S. & Powell, B., Mar 20 2015, In : Journal of Clinical Oncology. 33, 11, p. 1252-1257 6 p.

Research output: Contribution to journalArticle

amonafide
Daunorubicin
Cytarabine
Dilatation and Curettage
Acute Myeloid Leukemia
266 Citations (Scopus)

Ruxolitinib versus standard therapy for the treatment of polycythemia vera

Vannucchi, A. M., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Mesa, R., He, S., Jones, M. M., Garrett, W., Li, J., Pirron, U., Habr, D. & Verstovsek, S., Jan 1 2015, In : New England Journal of Medicine. 372, 5, p. 426-435 10 p.

Research output: Contribution to journalArticle

Polycythemia Vera
Hydroxyurea
Hematocrit
Therapeutics
Janus Kinase 1
92 Citations (Scopus)

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial

Pardanani, A., Harrison, C., Cortes, J. E., Cervantes, F., Mesa, R. A., Milligan, D., Masszi, T., Mishchenko, E., Jourdan, E., Vannucchi, A. M., Drummond, M. W., Jurgutis, M., Kuliczkowski, K., Gheorghita, E., Passamonti, F., Neumann, F., Patki, A., Gao, G. & Tefferi, A., Aug 1 2015, In : JAMA oncology. 1, 5, p. 643-651 9 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Randomized Controlled Trials
Safety
Essential Thrombocythemia
Polycythemia Vera
129 Citations (Scopus)

Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., Blaise, D., Ciceri, F., Corbacioglu, S., Dalle, J. H., Duarte, R. F., Fukuda, T., Huynh, A., Masszi, T., Michallet, M., Nagler, A. & 10 others, Nichonghaile, M., Pagluica, T., Peters, C., Petersen, F. B., Richardson, P. G., Ruutu, T., Savani, B. N., Wallhult, E., Yakoub-Agha, I. & Carreras, E., Jun 4 2015, In : Bone Marrow Transplantation. 50, 6, p. 781-789 9 p.

Research output: Contribution to journalArticle

Hepatic Veno-Occlusive Disease
Transplantation
Bone Marrow
Biomarkers
Prospective Studies
11 Citations (Scopus)

The potential role of HLA-DRB1∗11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Szilvasi, A., Rajczy, K., Inotai, D., Gopcsa, L., Lengyel, L., Barta, A., Reti, M., Tordai, A. & Masszi, T., Oct 1 2015, In : Bone Marrow Transplantation. 50, 10, p. 1321-1325 5 p.

Research output: Contribution to journalArticle

Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
2014
66 Citations (Scopus)

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, C., Brümmendorf, T. H., Kim, D. W., Turkina, A. G., Masszi, T., Assouline, S., Durrant, S., Kantarjian, H. M., Khoury, H. J., Zaritskey, A., Shen, Z. X., Jin, J., Vellenga, E., Pasquini, R., Mathews, V., Cervantes, F., Besson, N., Turnbull, K., Leip, E., Kelly, V. & 1 others, Cortes, J. E., 2014, In : American Journal of Hematology. 89, 7, p. 732-742 11 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Safety
Cytogenetics
Therapeutics
src-Family Kinases

Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma

Bérczi, V., Rudas, G., Kozák, L. R. U., Györke, T., Mikala, G., Masszi, T., Kalina, I. & Kaposi, P. N., 2014, In : World Journal of Surgical Oncology. 12, p. 271 1 p.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Plasmacytoma
Subclavian Artery
Multiple Myeloma
Neoplasms
60 Citations (Scopus)

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Andrikovics, H., Krahling, T., Balassa, K., Halm, G., Bors, A., Koszarska, M., Batai, A., Dolgos, J., Csomor, J., Egyed, M., Sipos, A., Remenyi, P., Tordai, A. & Masszi, T., Jul 1 2014, In : Haematologica. 99, 7, p. 1184-1190 7 p.

Research output: Contribution to journalArticle

Calreticulin
Janus Kinase 2
Essential Thrombocythemia
Mutation
Primary Myelofibrosis
4 Citations (Scopus)

Komplex molekuláris genetikai vizsgálati algoritmus myeloproliferativ neoplasiák diagnosztikájában

Translated title of the contribution: Complex molecular genetic diagnostic algorithm in the diagnosis of myeloproliferative neoplasmsKrhling, T., Balassa, K., Meggyesi, N., Bors, A., Csomor, J., Bátai, Á., Halm, G., Egyed, M., Fekete, S., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., Dec 1 2014, In : Orvosi Hetilap. 155, 52, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Molecular Pathology
Calreticulin
Molecular Biology
Thrombopoietin Receptors
Mutation
4 Citations (Scopus)

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

Koszarska, M., Meggyesi, N., Bors, A., Batai, A., Csacsovszki, O., Lehoczky, E., Adam, E., Kozma, A., Lovas, N., Sipos, A., Krahling, T., Dolgos, J., Remenyi, P., Fekete, S., Masszi, T., Tordai, A. & Andrikovics, H., 2014, In : Leukemia and Lymphoma. 55, 7, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

fms-Like Tyrosine Kinase 3
Acute Myeloid Leukemia
Disease-Free Survival
Survival
Multivariate Analysis
2 Citations (Scopus)

Mennyit vár ma Magyarországon egy myelomás beteg a diagnózisig?

Translated title of the contribution: How long does a myeloma patient currently wait for the diagnosis in Hungary?Varga, G., Mikala, G., Andrikovics, H. & Masszi, T., Sep 1 2014, In : Orvosi Hetilap. 155, 39, p. 1538-1543 6 p.

Research output: Contribution to journalArticle

Hungary
Patient Identification Systems
Primary Care Physicians
Amyloidosis
Hematology
19 Citations (Scopus)

Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF

Reményi, P., Gopcsa, L., Marton, I., Réti, M., Mikala, G., Pető, M., Barta, A., Bátai, Á., Farkas, Z., Borbényi, Z., Csukly, Z., Bodó, I., Fábián, J., Király, Á., Lengyel, L., Piukovics, K., Torbágyi, É. & Masszi, T., Apr 1 2014, In : Advances in Therapy. 31, 4, p. 451-460 10 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Hematopoietic Stem Cell Mobilization
Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
Leukapheresis
30 Citations (Scopus)

Prospective international cohort study demonstrates inability of interim PET to predict treatment failure in diffuse large B-cell lymphoma

IAEA Lymphoma Study Group, Dec 1 2014, In : Journal of Nuclear Medicine. 55, 12, p. 1936-1944 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Treatment Failure
Cohort Studies
Confidence Intervals
Disease-Free Survival
2013
82 Citations (Scopus)

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.

Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., Socie, G., Sengelov, H., Michallet, M., Passweg, J., Veelken, H., Yakoub-Agha, I., Shimoni, A. & Mohty, M., Oct 1 2013, In : Journal of Clinical Oncology. 31, 28, p. 3549-3556 8 p.

Research output: Contribution to journalArticle

Busulfan
Whole-Body Irradiation
Hematopoietic Stem Cell Transplantation
Blood Group Antigens
Acute Myeloid Leukemia
9 Citations (Scopus)

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation

Janicsák, H., Masszi, T., Reményi, P., Ungvari, G. S. & Gazdag, G., Aug 2013, In : European Journal of Haematology. 91, 2, p. 135-140 6 p.

Research output: Contribution to journalArticle

Bone Marrow Transplantation
Quality of Life
Demography
Depression
Psychology
59 Citations (Scopus)

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

Ludwig, H., Viterbo, L., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Ricci, D., Cakana, A., Enny, C., Feng, H., Van De Velde, H. & Harousseau, J. L., Jan 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 247-255 9 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Stem Cell Transplantation
5 Citations (Scopus)

Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: A case report

Wágner, L., Lengyel, L., Mikala, G., Reményi, P., Piros, L., Csomor, J., Fábry, L., Tordai, A., Langer, R. & Masszi, T., Dec 2013, In : Transplantation Proceedings. 45, 10, p. 3705-3707 3 p.

Research output: Contribution to journalArticle

Treatment Failure
Multiple Myeloma
Bone Marrow Transplantation
Renal Insufficiency
Kidney
19 Citations (Scopus)

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

Koszarska, M., Bors, A., Feczko, A., Meggyesi, N., Batai, A., Csomor, J., Adam, E., Kozma, A., Orban, T. I., Lovas, N., Sipos, A., Karaszi, E., Dolgos, J., Fekete, S., Reichardt, J., Lehoczky, E., Masszi, T., Tordai, A. & Andrikovics, H., May 2013, In : Leukemia and Lymphoma. 54, 5, p. 1028-1035 8 p.

Research output: Contribution to journalArticle

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Mutation
Survival
Platelet Count
2012
5 Citations (Scopus)

Analyses of donor-derived keratinocytes in hairy and nonhairy skin biopsies of female patients following allogeneic male bone marrow transplantation

Nemeth, K., Key, S., Bottlik, G., Masszi, T., Mezey, E. & Kárpáti, S., Jan 1 2012, In : Stem Cells and Development. 21, 1, p. 152-157 6 p.

Research output: Contribution to journalArticle

Bone Marrow Transplantation
Keratinocytes
Tissue Donors
Biopsy
Skin
19 Citations (Scopus)

Characterization and function of histamine receptors in human bone marrow stromal cells

Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Búzás, E., Falus, A., Key, S., Masszi, T., Kárpáti, S. & Mezey, E., Feb 2012, In : Stem Cells. 30, 2, p. 222-231 10 p.

Research output: Contribution to journalArticle

Histamine Receptors
Mesenchymal Stromal Cells
Histamine
Interleukin-6
Artificial Cells
6 Citations (Scopus)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Computational Biology
Molecular Biology
Exons
Clonal Evolution
16 Citations (Scopus)

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis

Nicolini, F. E., Masszi, T., Shen, Z., Gallagher, N. J., Jootar, S., Powell, B. L., Dorlhiac-Llacer, P. E., Zheng, M., Szczudlo, T. & Turkina, A., May 2012, In : Leukemia and Lymphoma. 53, 5, p. 907-914 8 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Accelerated Phase
Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Multicenter Studies
Clinical Trials
27 Citations (Scopus)

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T. & Kim, D. W., Apr 2012, In : Leukemia Research. 36, 4, p. 438-442 5 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Quality of Life
Leukemia
Therapeutics
Protein-Tyrosine Kinases
62 Citations (Scopus)

High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry

for the Lymphoma Working Party of the European Blood and Marrow Transplantation Registry (EBMT), May 1 2012, In : Biology of Blood and Marrow Transplantation. 18, 5, p. 788-793 6 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Registries
Transplantation
Bone Marrow
14 Citations (Scopus)

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: Safety and efficacy data in a series of 21 patients from Europe and the USA

Douglas, K. W., Parker, A. N., Hayden, P. J., Rahemtulla, A., D'Addio, A., Lemoli, R. M., Rao, K., Maris, M., Pagliuca, A., Uberti, J., Scheid, C., Noppeney, R., Cook, G., Bokhari, S. W., Worel, N., Mikala, G., Masszi, T., Taylor, R. & Treisman, J., Jan 2012, In : Bone Marrow Transplantation. 47, 1, p. 18-23 6 p.

Research output: Contribution to journalArticle

Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
164 Citations (Scopus)

Superiority of the triple combination of bortezomib-thalidomide- dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: The MMVAR/IFM 2005-04 randomized phase III trial from the chronic leukemia working party of the European Group for blood and marrow transplantation

Garderet, L., Iacobelli, S., Moreau, P., Dib, M., Lafon, I., Niederwieser, D., Masszi, T., Fontan, J., Michallet, M., Gratwohl, A., Milone, G., Doyen, C., Pegourie, B., Hajek, R., Casassus, P., Kolb, B., Chaleteix, C., Hertenstein, B., Onida, F., Ludwig, H. & 10 others, Ketterer, N., Koenecke, C., Van Os, M., Mohty, M., Cakana, A., Gorin, N. C., De Witte, T., Harousseau, J. L., Morris, C. & Gahrton, G., Jul 10 2012, In : Journal of Clinical Oncology. 30, 20, p. 2475-2482 8 p.

Research output: Contribution to journalArticle

Thalidomide
Autologous Transplantation
Blood Group Antigens
Multiple Myeloma
Dexamethasone
2011
15 Citations (Scopus)

Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients

Meggyesi, N., Kozma, A., Halm, G., Nahajevszky, S., Bátai, Á., Fekete, S., Barta, A., Ujj, G., Lueff, S., Sipos, A., Ádám, E., Bors, A., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., Dec 2011, In : Acta Haematologica. 127, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chromosome Aberrations
Protein-Tyrosine Kinases
Mutation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8 Citations (Scopus)

Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

Mohl, A., Boda, Z., Jager, R., Losonczy, H., Marosi, A., Masszi, T., Nagy, E., Nemes, L., Obser, T., Oyen, F., Radványi, G., Schlammadinger, Á., Szélessy, Z. S., Várkonyi, A., Vezendy, K., Vilimi, B., Schneppenheim, R. & Bodó, I., May 2011, In : Journal of Thrombosis and Haemostasis. 9, 5, p. 945-952 8 p.

Research output: Contribution to journalArticle

Type 3 Von Willebrand's Disease
Isoantibodies
Gene Deletion
von Willebrand Factor
Mutation
3 Citations (Scopus)

Gram-negatív bacteriaemia neutropeniás hematológiai betegekben. Tapasztalatok fluorokinolonprofilaxis alkalmazása kapcsán

Translated title of the contribution: Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolonesSinkó, J., Cser, V., Konkoly Thege, M. & Masszi, T., Jul 1 2011, In : Orvosi Hetilap. 152, 27, p. 1063-1067 5 p.

Research output: Contribution to journalArticle

Fluoroquinolones
Bacteremia
Mortality
Incidence
Stem Cell Transplantation
31 Citations (Scopus)

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Basic-Kinda, S., Mayer, J., Masszi, T., Giebel, S., Labar, B. & Wiktor-Jedrzejczak, W., Jun 2011, In : European Journal of Haematology. 86, 6, p. 488-495 8 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Stem Cells
Stem Cell Transplantation
20 Citations (Scopus)

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization

Basak, G. W., Jaksic, O., Koristek, Z., Mikala, G., Mayer, J., Masszi, T., Labar, B. & Wiktor-Jedrzejczak, W., Jul 2011, In : American Journal of Hematology. 86, 7, p. 550-553 4 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Odds Ratio
Melphalan
Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
8 Citations (Scopus)

Lymphoid aggregates may contribute to the migration and epithelial commitment of Bone marrow-derived cells in colonic mucosa

Valcz, G., Krenács, T., Sípos, F., Patai, Á. V., Wichmann, B., Leiszter, K., Tóth, K., Balogh, Z., Csizmadia, A., Hagymási, K., Masszi, T., Molnár, B. & Tulassay, Z., Sep 2011, In : Journal of Clinical Pathology. 64, 9, p. 771-775 5 p.

Research output: Contribution to journalArticle

Bone Marrow Cells
Mucous Membrane
Colitis
Mesenchymal Stromal Cells
Fluorescent Antibody Technique
21 Citations (Scopus)

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: It's not too late

Basak, G. W., Mikala, G., Koristek, Z., Jaksic, O., Basic-Kinda, S., Cegledi, A., Reti, M., Masszi, T., Mayer, J., Giebel, S., Hbel, K., Labar, B. & Wiktor-Jedrzejczak, W., Sep 2011, In : Leukemia and Lymphoma. 52, 9, p. 1711-1719 9 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Drug Therapy
Granulocyte Colony-Stimulating Factor
Leukocyte Count
Blood Cells
3 Citations (Scopus)

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Györke, T., Kollár, A., Bottlik, G., Szepesi, Á., Bodó, I., Masszi, T., Bérczi, V. & Garai, I., Apr 2011, In : International Journal of Hematology. 93, 4, p. 545-550 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Lymph Nodes
Biopsy
Drug Therapy
Minimally Invasive Surgical Procedures
2010
18 Citations (Scopus)

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

Gézsi, A., Budde, U., Deák, I., Nagy, E., Mohl, A., Schlammadinger, Á., Boda, Z., Masszi, T., Sadler, J. E. & Bodó, I., Jun 2010, In : Journal of Thrombosis and Haemostasis. 8, 6, p. 1273-1280 8 p.

Research output: Contribution to journalArticle

von Willebrand Diseases
von Willebrand Factor
Half-Life
Theoretical Models
Deamino Arginine Vasopressin
9 Citations (Scopus)

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Skribek, H., Otvos, R., Flaberg, E., Nagy, N., Markasz, L., Eksborg, S., Masszi, T., Kozma, A., Adam, E., Miseta, A., Klein, E. & Szekely, L., Dec 2010, In : Experimental Hematology. 38, 12, p. 1219-1230 12 p.

Research output: Contribution to journalArticle

Lymphoid Leukemia
Epirubicin
Daunorubicin
Prednisolone
Doxorubicin
87 Citations (Scopus)

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: Efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily

Saglio, G., Hochhaus, A., Goh, Y. T., Masszi, T., Pasquini, R., Maloisel, F., Erben, P., Cortes, J., Paquette, R., Bradley-Garelik, M. B., Zhu, C. & Dombret, H., Aug 15 2010, In : Cancer. 116, 16, p. 3852-3861 10 p.

Research output: Contribution to journalArticle

Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Dasatinib
Philadelphia Chromosome
18 Citations (Scopus)

JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia

Andrikovics, H., Nahajevszky, S., Koszarska, M., Meggyesi, N., Bors, A., Halm, G., Lueff, S., Lovas, N., Matrai, Z., Csomor, J., Rasonyi, R., Egyed, M., Várkonyi, J., Mikala, G., Sipos, A., Kozma, A., Adam, E., Fekete, S., Masszi, T. & Tordai, A., Oct 2010, In : Leukemia. 24, 10, p. 1809-1813 5 p.

Research output: Contribution to journalArticle

Janus Kinase 2
Myeloproliferative Disorders
Acute Myeloid Leukemia
Haplotypes
Single Nucleotide Polymorphism
7 Citations (Scopus)

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the european group for blood and marrow transplantation

Cesaro, S., Marsh, J., Tridello, G., Rovò, A., Maury, S., Montante, B., Masszi, T., Van Lint, M. T., Afanasyev, B., Iriondo Atienza, A., Bierings, M., Carbone, C., Doubek, M., Lanino, E., Sarhan, M., Risitano, A., Steinerova, K., Wahlin, A., Pegoraro, A. & Passweg, J., Jul 2010, In : Acta Haematologica. 124, 1, p. 19-22 4 p.

Research output: Contribution to journalArticle

Aplastic Anemia
Blood Group Antigens
Autoimmune Diseases
Registries
Transplantation
5 Citations (Scopus)

Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration

Marschalkó, M., Eros, N., Holló, P., Hársing, J., Bottlik, G., Bátai, Á., Csukly, Z., Masszi, T., Szentirmai, Z., Fodor, J., Kárpáti, S., Matolcsy, A. & Csomor, J., Oct 2010, In : American Journal of Dermatopathology. 32, 7, p. 708-712 5 p.

Research output: Contribution to journalArticle

Lymphomatoid Papulosis
Anaplastic Large-Cell Lymphoma
Primary Cutaneous Anaplastic Large Cell Lymphoma
Lymph Nodes
T-Cell Receptor gamma Genes
2009
4 Citations (Scopus)

A csontvelô eredetû ôssejtek megjelenése az ép vastagbélhámban és a gyulladást követô hámregenerációban.

Translated title of the contribution: Appearing of bone marrow derived stem cells in healthy and regenerating colonic epitheliumValcz, G., Krenács, T., Sípos, F., Wichmann, B., Tóth, K., Leiszter, K., Balogh, Z., Csizmadia, A., Hagymási, K., Müzes, G., Masszi, T., Molnár, B. & Tulassay, Z., Oct 4 2009, In : Orvosi Hetilap. 150, 40, p. 1852-1857 6 p.

Research output: Contribution to journalArticle

Regeneration
Stem Cells
Epithelium
Bone Marrow
Inflammation
99 Citations (Scopus)

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

Harousseau, J. L., Martinelli, G., Jedrzejczak, W. W., Brandwein, J. M., Bordessoule, D., Masszi, T., Ossenkoppele, G. J., Alexeeva, J. A., Beutel, G., Maertens, J., Vidriales, M. B., Dombret, H., Thomas, X., Burnett, A. K., Robak, T., Khuageva, N. K., Golenkov, A. K., Tothova, E., Mollgard, L., Park, Y. C. & 3 others, Bessems, A., De Porre, P. & Howes, A. J., 2009, In : Blood. 114, 6, p. 1166-1173 8 p.

Research output: Contribution to journalArticle

tipifarnib
Hydroxyurea
Acute Myeloid Leukemia
Survival
Therapeutics

Familial multiple myeloma. Two more families

Várkonyi, J., Farkas, P., Tamáska, J., Masszi, T., Gopcsa, L., Padányi, Á. & Rajczy, K., Dec 2009, In : Central European Journal of Medicine. 4, 4, p. 501-505 5 p.

Research output: Contribution to journalArticle

Environmental Exposure
Heterozygote
Multiple Myeloma
HLA-B51 Antigen
HLA-DR4 Antigen
7 Citations (Scopus)

HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease

Andrikovics, H., Meggyesi, N., Szilvasi, A., Tamaska, J., Halm, G., Lueff, S., Nahajevszky, S., Egyed, M., Várkonyi, J., Mikala, G., Sipos, A., Kalasz, L., Masszi, T. & Tordai, A., Mar 2009, In : Cancer Epidemiology Biomarkers and Prevention. 18, 3, p. 929-934 6 p.

Research output: Contribution to journalArticle

Myeloproliferative Disorders
Disease Susceptibility
Chronic Disease
Mutation
Iron
25 Citations (Scopus)

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

Giebel, S., Labopin, M., Holowiecki, J., Labar, B., Komarnicki, M., Koza, V., Masszi, T., Mistrik, M., Lange, A., Hellmann, A., Vitek, A., Pretnar, J., Mayer, J., Rzepecki, P., Indrak, K., Wiktor-Jedrzejczak, W., Wojnar, J., Krawczyk-Kulis, M., Kyrcz-Krzemien, S. & Rocha, V., 2009, In : Annals of Hematology. 88, 10, p. 1005-1013 9 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Leukemia
Mortality
Incidence
Recurrence
12 Citations (Scopus)

Serum β2-microglobulin measured by immunonephelometry: Expression patterns and reference intervals in healthy adults

Mátrai, Z., Németh, J., Miklós, K., Szabó, Z. & Masszi, T., May 1 2009, In : Clinical Chemistry and Laboratory Medicine. 47, 5, p. 585-589 5 p.

Research output: Contribution to journalArticle

Population Characteristics
Blood Donors
Serum
Blood
Statistics
125 Citations (Scopus)

VMP (Bortezomib, melphalan, and prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: Cohort analysis of the phase III VISTA study

Dimopoulos, M. A., Richardson, P. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kastritis, E., Kropff, M., Petrucci, M. T., Delforge, M., Alexeeva, J., Schots, R., Masszi, T., Mateos, M. V., Deraedt, W., Liu, K., Cakana, A., Van De Velde, H. & San Miguel, J. F., Dec 20 2009, In : Journal of Clinical Oncology. 27, 36, p. 6086-6093 8 p.

Research output: Contribution to journalArticle

Melphalan
Prednisone
Multiple Myeloma
Cohort Studies
Kidney
2008
18 Citations (Scopus)

An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary

Mohl, A., Marschalek, R., Masszi, T., Nagy, E., Obser, T., Oyen, F., Sallai, K., Bodó, I. & Schneppenheim, R., 2008, In : Journal of Thrombosis and Haemostasis. 6, 10, p. 1729-1735 7 p.

Research output: Contribution to journalArticle

Type 3 Von Willebrand's Disease
Hungary
von Willebrand Factor
von Willebrand Diseases
Genetic Recombination
23 Citations (Scopus)

Analysis of platelet α2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy

Béres, B. J., Tóth-Zsámboki, E., Vargová, K., László, Á., Masszi, T., Kerecsen, G., Préda, I. & Kiss, R., Nov 2008, In : Thrombosis and Haemostasis. 100, 5, p. 829-836 8 p.

Research output: Contribution to journalArticle

Adrenergic Receptors
Coronary Artery Disease
Blood Platelets
Adenosine Diphosphate
Epinephrine